Image

Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults

Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults

Recruiting
20-80 years
All
Phase N/A

Powered by AI

Overview

This study aims to explore how young adults, older adults and people with Parkinson's disease (PwP), perceive their abilty to cross obstacles while walking, and how this perception is related to their actual performance of obstacle crossing and disease-related motor and cognitive impairments. The study will explore this percepeption and the actual performance in different walking environments(floor, synthetic grass turf). Understanding how people perceive obstacles may help improve rehabilitation methods and reduce the risk of falls. The study will take place at the Motor Performance Laboratory, University of Haifa, and will include walking tasks, eye-tracking measurements, and motor and cognitive assessments.

Description

This study investigates the role of affordance perception - the ability to perceive opportunities for action - during obstacle crossing in people with Parkinson's disease (PwP). Falls are highly prevalent in PwP, often resulting from tripping over obstacles. While previous research has mainly focused on gait impairments, this study uniquely examines the perceptual stage that precedes movement and the association between perception, cognition, and motor performance.

Participants will include 60 PwP and 120 healthy adults (60 older adults and 60 young adults). All participants will perform walking tasks involving obstacle crossing under different environmental conditions (e.g., different obstacle heights and surfaces). Prior to walking, participants will judge whether they can safely cross the obstacle. Eye-tracking glasses will measure visual exploration patterns to assess how participants scan the environment. Additionally, walking variables such as speed and step length, will be recorded using wearable sensors.

The study will explore:

  1. Differences in affordance perception between PwP and healthy adults.
  2. Associations between motor and cognitive impairments and affordance perception in PwP.
  3. How affordance perception relates to gait performance during obstacle crossing.

Results from this study may help to develop new intervention strategies aimed at improving safe walking and obstacle negotiation in PwP.

Eligibility

Inclusion Criteria:

  • Participants aged 20 to 80 years.
  • Ability to walk independently outdoors without assistive devices.
  • For Parkinson's Disease (PD) group: Diagnosis of PD confirmed by medical records.
  • For healthy control groups: No neurological or orthopedic conditions affecting gait.

Exclusion Criteria:

  • Feezing of gait (for PD group only), based on a score greater than 0 on the Freezing of Gait Questionnaire.
  • Severe visual impairment that cannot be corrected with glasses or lenses.
  • Cognitive impairment, defined as a score below 18 on the telephone-based Mini-Mental State Examination (MMSE).
  • Any orthopedic condition, pain, or other medical condition that may affect walking, based on self-report.

Study details
    Parkinson's Disease (PD)

NCT06932679

University of Haifa

2 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.